EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Novel insights into taxane pharmacology: An update on drug resistance mechanisms, immunomodulation and drug delivery strategies

Giovanni Luca Beretta, Giuliana Cassinelli, Giacomina Rossi, Amalia Azzariti, Iléana Corbeau, Diego Tosi, Paola Perego

Drug Resistance Updates · 2025-07 · 81 · 101223

DOI: 10.1016/j.drup.2025.101223 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Drug Resistance Updates, 2025-07. Verfasst von Giovanni Luca Beretta und 6 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Pharmacology Unit, Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, via Amadeo 42, Milan 20133, Italy. …. Hauptthemen laut MEDLINE: Taxoids, Drug Resistance, Neoplasm, Drug Delivery Systems, Neoplasms. Die Arbeit wurde bisher 42-mal zitiert (Crossref) und nennt 239 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Associazione Italiana per la Ricerca sul Cancro, Ministry of Health, European Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Taxanes are effective in several solid tumors. Paclitaxel, the main clinically available taxane, was approved in the early nineties, for the treatment of ovarian cancer and later on, together with the analogs docetaxel and cabazitaxel, for other malignancies. By interfering with microtubule function and impairing the separation of sister cells at mitosis, taxanes act as antimitotic agents, thereby counteracting the high proliferation rate of cancer cells. The action of taxanes goes beyond their antimitotic function because their main cellular targets, the microtubules, participate in multiple processes such as intracellular transport and cell shape maintenance. The clinical efficacy of taxanes is limited by the development of multiple resistance mechanisms. Among these, extracellular vesicles have emerged as new players. In addition, taxane metronomic schedules shows an impact on the tumor microenvironment reflected by antiangiogenic and immunomodulatory effects, an aspect of growing interest considering their inclusion in treatment regimens with immunotherapeutics. Preclinical studies have paved the bases for synergistic combinations of taxanes both with conventional and targeted agents. A variety of drug delivery strategies have provided novel opportunities to increase the drug activity. The ability of taxanes to orchestrate different cellular effects amenable to modulation suggests novel options to improve cures in lethal malignancies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TaxoidsDrug Resistance, NeoplasmDrug Delivery SystemsNeoplasmsAntineoplastic AgentsHumansTumor MicroenvironmentImmunomodulationAnimalsMicrotubules

Stichwörter der Autor:innen

Drug combinationDrug deliveryDrug resistanceImmunomodulationPaclitaxelTaxanes

Substanzen

TaxoidsAntineoplastic Agents

Autor:innen und Institutionen

  • Molecular Pharmacology Unit, Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, via Amadeo 42, Milan 20133, Italy. Electronic address: giovanni.beretta@istitutotumori.mi.it.
  • Molecular Pharmacology Unit, Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, via Amadeo 42, Milan 20133, Italy. Electronic address: giuliana.cassinelli@istitutotumori.mi.it.
  • Unit of Neurology 8, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan 20133, Italy. Electronic address: Giacomina.Rossi@istituto-besta.it.
  • Laboratory of Experimental Pharmacology, IRCCS Istituto Tumori Giovanni Paolo II, V.le O. Flacco, 65, Bari 70124, Italy. Electronic address: a.azzariti@oncologico.bari.it.
  • Early Clinical Trial Unit, Medical Oncology Department, Institut régional du Cancer de Montpellier, Inserm U1194, Montpellier University, 208, rue de Apothicaires, 34298 Montpellier, France; Fondazione Gianni Bonadonna,…
  • Molecular Pharmacology Unit, Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, via Amadeo 42, Milan 20133, Italy. Electronic address: paola.perego@istitutotumori.mi.it.

Förderung

  • Associazione Italiana per la Ricerca sul Cancro
  • Ministry of Health
  • European Commission

Zitieren

APA

Beretta, G. L., Cassinelli, G., Rossi, G., Azzariti, A., Corbeau, I., Tosi, D., & Perego, P. (2025). Novel insights into taxane pharmacology: An update on drug resistance mechanisms, immunomodulation and drug delivery strategies. Drug Resistance Updates, 81, 101223. https://doi.org/10.1016/j.drup.2025.101223

Vancouver

Beretta GL, Cassinelli G, Rossi G, Azzariti A, Corbeau I, Tosi D, et al. Novel insights into taxane pharmacology: An update on drug resistance mechanisms, immunomodulation and drug delivery strategies. Drug Resistance Updates. 2025;81:101223. doi:10.1016/j.drup.2025.101223

BibTeX
@article{Beretta2025,
  author = {Beretta, Giovanni Luca and Cassinelli, Giuliana and Rossi, Giacomina and Azzariti, Amalia and Corbeau, Iléana and Tosi, Diego and Perego, Paola},
  title = {Novel insights into taxane pharmacology: An update on drug resistance mechanisms, immunomodulation and drug delivery strategies},
  journal = {Drug Resistance Updates},
  year = {2025},
  volume = {81},
  pages = {101223},
  doi = {10.1016/j.drup.2025.101223}
}
Kostenlos starten →